NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002377

Registered date:28/04/2010

PEG-IFN-alfa2b/Ribavirin combination therapy for chronic hepatitis C patients with low platelet count: efficacy and safety

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedchronic hepatitis C
Date of first enrollment2009/10/01
Target sample size100
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Peg-IFN-alfa2b/Ribavirin thrapy

Outcome(s)

Primary OutcomeEfficacy
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriacontraindication of Peg-IFN/Ribavirin thrapy

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail s-kaneko@umin.ac.jp
Affiliation Kanazawa university University hospital
scientific contact
Name Shuichi Kaneko
Address Takara-Machi, Kanazawa, Ishikawa, Japan Japan
Telephone
E-mail
Affiliation Kanazawa university Graduate school of meicine